Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

android tablet pc

Home > Press > Arrowhead CEO Comments on Recent Nasdaq Letter

Arrowhead Research Corporation's (NASDAQ: ARWR) ("the Company") President and Chief Executive Officer today issued the following open letter to the Company's shareholders:

Arrowhead CEO Comments on Recent Nasdaq Letter

PASADENA, CA | Posted on February 18th, 2009

Dear Shareholders:

On Friday, February 13, we announced that we had received a letter from the Nasdaq Stock Market ("Nasdaq") informing us that Arrowhead has fallen below the minimum stockholder equity requirement for the Nasdaq Global Market and that our listing is currently under review. Based on stockholder inquiries received by the Company today, I wanted to provide additional information about the review process and what this means for Arrowhead.

During the review period, Arrowhead common stock will continue to trade on the Nasdaq Global Market. Under Nasdaq rules, Arrowhead may submit a formal plan to regain compliance with Nasdaq Global Market continued listing standards on or before February 26, 2009, and we are currently preparing the submission. If the plan is accepted, Nasdaq can grant the Company a 105-day extension to regain compliance.

Should the Nasdaq not accept our compliance plan, we would seek to transfer the listing of our common stock from the Nasdaq Global Market to the Nasdaq Capital Market. The Nasdaq Capital Market is one of the three market tier designations for Nasdaq-listed stocks and operates in substantially the same manner as the Nasdaq Global Market, although it has a lower stockholder equity requirement than the Nasdaq Global Market.

We remain optimistic about our business in these challenging times, and we believe that we will be able to continue our progress whether our stock is listed on the Nasdaq Global Market or the Nasdaq Capital Market.

I invite all investors to listen to the conference call for an in-depth review of Arrowhead and its subsidiaries' growth catalysts and market opportunity. An archive of the First Quarter Fiscal 2009 conference call is located at the following link:

On behalf of Arrowhead, we look forward to your continued support.
Christopher Anzalone
Chief Executive Officer


About Arrowhead Research Corporation
Arrowhead Research Corporation ( (NASDAQ: ARWR) is a nanotechnology company commercializing new technologies in the areas of life sciences, electronics, and energy. Arrowhead is seeking to build value for shareholders through the progress of majority owned subsidiaries. Currently, Arrowhead has four subsidiaries commercializing nanotech products and applications and investments in two minority-owned subsidiaries.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties. For example, there can be no assurance that we will be able to maintain our listing on any NASDAQ market, that our financial initiatives will succeed in strengthening our balance sheet or that we will be able to continue to operate as a going concern. Arrowhead Research Corporation's Annual Report on Form 10-K and 10-K/A, recent and forthcoming Quarterly Reports on Form 10-Q and 10-Q/A, recent Current Reports on Forms 8-K and 8-K/A, our Registration Statements on Form S-3, and other SEC filings discuss these and other important risk factors that may affect our business, results of operations and financial condition. We disclaim any intent to revise or update publicly any forward-looking statements.

For more information, please click here

Virginia Dadey

Copyright © Arrowhead Research Corporation

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Sopping up proteins with thermosponges: Researchers develop novel nanoparticle platform that proves effective in delivering protein-based drugs October 22nd, 2014

Brookhaven Lab Launches Computational Science Initiative:Leveraging computational science expertise and investments across the Laboratory to tackle "big data" challenges October 22nd, 2014

Bipolar Disorder Discovery at the Nano Level: Tiny structures found in brain synapses help scientists better understand disorder October 22nd, 2014

NIST offers electronics industry 2 ways to snoop on self-organizing molecules October 22nd, 2014


TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014

Arrowhead Issues Open Letter to Shareholders October 9th, 2014

PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014

Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014


NanoTechnology for Defense (NT4D) October 22nd, 2014

Mechanism behind nature's sparkles revealed October 22nd, 2014

TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014

Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE